Add to ORKGAlthough evidence for efficacy of antipsychotic polypharmacy (APP) is sparse, APP is common in schizophrenia. The national Danish health registers were accessed to examine in schizophrenia patients: (1) cross-sectional prevalences of APP (1996-2012); (2) geographic variations in APP (2012); and (3) correlates of APP (2012). APP increased from 17.2% in 1996 to 30.8% in 2006 (
Clozapine is the gold standard for treating treatment-resistant schizophrenia (TRS) although widely ...
ObjectiveEven though all guidelines recommend generally against antipsychotic polypharmacy, antipsyc...
The present study investigated the use of antipsychotics in a sample of clinically unstable patients...
Although evidence for efficacy of antipsychotic polypharmacy (APP) is sparse, APP is common in schiz...
Objective: This study aimed to identify trends in the use of antipsychotic polypharmacy (APP) and th...
Objective: This study aimed to identify trends in the use of antipsychotic polypharmacy (APP) and th...
Objective: The aim of our study was to examine the prevalence of and factors associated with antipsy...
The purpose of this study was to calculate the proportion of patients with schizophrenia receiving p...
International audienceIntroduction: Antipsychotic polypharmacy (APP), defined as the use of more tha...
Objectives: Antipsychotic polypharmacy (APP) is common worldwide in the treatment of schizophrenia. ...
Objective: The co-prescription of multiple antipsychotic drugs continues to increase despite a lack ...
Background: Surveys on prescription patterns for antipsychotics in the Scandinavian public health sy...
Aim: To explore the evolution of antipsychotic polypharmacy (APP) and other psychotropic prescribing...
Objective: To analyze prescribing patterns of chronic psychiatric patients living in sheltered housi...
Objective: To analyze prescribing patterns of chronic psychiatric patients living in sheltered housi...
Clozapine is the gold standard for treating treatment-resistant schizophrenia (TRS) although widely ...
ObjectiveEven though all guidelines recommend generally against antipsychotic polypharmacy, antipsyc...
The present study investigated the use of antipsychotics in a sample of clinically unstable patients...
Although evidence for efficacy of antipsychotic polypharmacy (APP) is sparse, APP is common in schiz...
Objective: This study aimed to identify trends in the use of antipsychotic polypharmacy (APP) and th...
Objective: This study aimed to identify trends in the use of antipsychotic polypharmacy (APP) and th...
Objective: The aim of our study was to examine the prevalence of and factors associated with antipsy...
The purpose of this study was to calculate the proportion of patients with schizophrenia receiving p...
International audienceIntroduction: Antipsychotic polypharmacy (APP), defined as the use of more tha...
Objectives: Antipsychotic polypharmacy (APP) is common worldwide in the treatment of schizophrenia. ...
Objective: The co-prescription of multiple antipsychotic drugs continues to increase despite a lack ...
Background: Surveys on prescription patterns for antipsychotics in the Scandinavian public health sy...
Aim: To explore the evolution of antipsychotic polypharmacy (APP) and other psychotropic prescribing...
Objective: To analyze prescribing patterns of chronic psychiatric patients living in sheltered housi...
Objective: To analyze prescribing patterns of chronic psychiatric patients living in sheltered housi...
Clozapine is the gold standard for treating treatment-resistant schizophrenia (TRS) although widely ...
ObjectiveEven though all guidelines recommend generally against antipsychotic polypharmacy, antipsyc...
The present study investigated the use of antipsychotics in a sample of clinically unstable patients...